Page last updated: 2024-10-29

ketoconazole and Neglected Diseases

ketoconazole has been researched along with Neglected Diseases in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Neglected Diseases: Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sykes, ML1
Avery, VM1
Fahal, AH1

Reviews

1 review available for ketoconazole and Neglected Diseases

ArticleYear
Approaches to protozoan drug discovery: phenotypic screening.
    Journal of medicinal chemistry, 2013, Oct-24, Volume: 56, Issue:20

    Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; P

2013

Other Studies

1 other study available for ketoconazole and Neglected Diseases

ArticleYear
Mycetoma: A global medical and socio-economic dilemma.
    PLoS neglected tropical diseases, 2017, Volume: 11, Issue:4

    Topics: Antifungal Agents; Biomedical Research; Cost-Benefit Analysis; Global Health; Health Services Access

2017